CN111419906A - Medicament for treating neocoronary pneumonia - Google Patents

Medicament for treating neocoronary pneumonia Download PDF

Info

Publication number
CN111419906A
CN111419906A CN202010249582.2A CN202010249582A CN111419906A CN 111419906 A CN111419906 A CN 111419906A CN 202010249582 A CN202010249582 A CN 202010249582A CN 111419906 A CN111419906 A CN 111419906A
Authority
CN
China
Prior art keywords
medicament
ethanol
lung
air
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010249582.2A
Other languages
Chinese (zh)
Inventor
柳保来
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN111419906A publication Critical patent/CN111419906A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/12Preparation of respiratory gases or vapours by mixing different gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The technology utilizes the characteristics of strong ethanol penetration, easy volatilization, no residue, no toxicity, small damage and good inactivation effect on new coronavirus and influenza virus, and is matched with lung which is easy to dissolve in ethanol and clear away heat and toxic materials, and the new coronavirus and influenza virus inactivation medicament is prepared by cool and easy volatile natural menthol, jasmine flower essential oil with the functions of refreshing and relieving cough and distilled water. It is characterized in that: adopts natural nontoxic raw materials, and has no toxic and side effects on human body. Oxygen or air is injected into the tank body medicament, the heating air is utilized to promote the medicament to evaporate, and the medicament and the oxygen or air form ethanol mixed gas with a certain concentration, and the ethanol mixed gas is directly sucked into the lung through a respiratory tract by a respirator, so that the ethanol gas directly acts to destroy the virus protein structure, the protein has no physiological activity any more, loses the infection pathogenicity and the replication and proliferation capacity, and the purpose of inactivating viruses is achieved.

Description

Medicament for treating neocoronary pneumonia
Technical neck area: medicine, a preparation for rapid inactivation of coronavirus and influenza virus transmitted through the suction tract.
Background art:
the new coronavirus is a virus which is not contacted with human beings, and the human beings do not have immunity to the virus, are generally susceptible to infection, have high morbidity and cause infection, morbidity and death of a large number of people. In the future, the virus may be mutated or new virus may appear, and the vaccine preparation is slow.
The invention content is as follows:
the invention is a medicament prepared by combining distilled water with the characteristics of easy volatilization, strong penetration, little harm to human body, menthol for clearing heat and detoxicating, easy volatilization and cooling.
The jasmine essential oil comprises the following components in percentage by weight: 80% of ethanol, 0.5% of menthol (natural), 0.2% of jasmine essential oil and 19.2% of distilled water.
The manufacturing process comprises the following steps:
firstly, filtering the ethanol by using active carbon to remove toxic substances contained in the ethanol. Dissolving Mentholum and flos Jasmini sambac essential oil, adding distilled water to obtain medicinal liquid, sealing the medicinal liquid in a medicinal pot, heating the bottom of the medicinal pot with a heater to volatilize the medicinal liquid, and injecting oxygen or air into the medicinal liquid pot. The mixed gas is firstly sucked into the deep lung from the oral cavity through the respirator, then is spitted out for about one minute from the oral cavity, and then is normally sucked for about one minute by changing the nostril, so that the ethanol with strong penetrating power directly acts on the coronavirus on the oral mucosa, the nasal cavity, the pharynx, the larynx, the trachea, the bronchus and the lung cells, the denaturation, dehydration and solidification structures of virus protein are damaged, the protein has no physiological activity any more, the infection pathogenicity and the replication and proliferation capacity are lost, and simultaneously oxygen or air exchanges qi and blood in the lung to ensure that the body does not lack oxygen.
Description of the drawings: FIG. 1 is a schematic diagram of the abstract drawing
As shown in the figure: 1. a respiratory mask 2 and an air outlet pipe; 3. a medicine storage tank; 4. liquid medicine; 5. a heater; 6. an air inlet pipe; 7. an air valve; 8. a gas cylinder; 9. sealing cover
Detailed description of the preferred embodiments
The use method comprises the following steps:
1. firstly, the prepared liquid medicine is poured into a nontoxic and heatable medicine tank 3, and a sealing cover 9 is covered.
2. The air inlet pipe 6 is connected with the air inlet valve 7 of the air storage bottle 8 and the medicine storage tank 3, and the outlet of the air inlet pipe is arranged at the bottom of the medicine storage tank 3.
3. The air outlet pipe 2 is connected with the respirator 1 and the medicine storage tank 3, and the air outlet is arranged above the medicine storage tank 3 and close to the sealing cover 9.
4. The heater at the bottom of the medicine storage tank 3 and the medicine feeding liquid 5 are heated to about 75 ℃ to promote the volatilization of the ethanol and increase the concentration and the humidity of the ethanol gas.
5. When a patient inhales, the patient inhales ethanol, oxygen or air mixed gas through the mouth cavity through the respirator, the high-concentration ethanol enters the lung and is combined with the moisture in the mouth cavity and the moisture in the mucous membrane of the respiratory tract, so that the concentration of the ethanol reaches the optimal concentration for inactivating viruses, the oxygen or air entering the lung is combined with the blood in the lung together, the body is kept from oxygen deficiency, and then the carbon dioxide and waste gas are discharged from the mouth cavity. Repeating the operation for about one minute, and inhaling the medicine from the nostril for about one minute to normally breathe, thereby inactivating the respiratory viruses.
The second usage:
the medicament is directly pressurized and atomized, is firstly sucked into the deep part of the lung from the mouth of a respirator for about one minute, and then is normally breathed for about one minute, so that the medicament is contacted with virus to complete virus inactivation.
The application method is as follows:
and injecting the ethanol mixed gas into the deep part of the lung by matching the intubation tube with a breathing machine to finish virus inactivation.

Claims (4)

1. A medicine for deactivating the virus of respiratory tract is prepared from alcohol, natural menthol, jasmine oil and distilled water through heating the medicine to become volatile gas, and introducing it into lung.
2. The method comprises the following steps of 1: ethanol, natural menthol, jasmine essential oil and distilled water.
3. The method comprises the following steps of 1: the medicament gas-making device is provided with a heater for promoting the volatilization of the medicament.
4. The method comprises the following steps of 1: the gas passes through the respiratory tract. Directly acts on the application mode of inactivating the virus.
CN202010249582.2A 2020-03-04 2020-03-26 Medicament for treating neocoronary pneumonia Pending CN111419906A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010150252 2020-03-04
CN2020101502528 2020-03-04

Publications (1)

Publication Number Publication Date
CN111419906A true CN111419906A (en) 2020-07-17

Family

ID=71557354

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010249582.2A Pending CN111419906A (en) 2020-03-04 2020-03-26 Medicament for treating neocoronary pneumonia

Country Status (1)

Country Link
CN (1) CN111419906A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005802A1 (en) * 2000-07-17 2002-01-24 Saburo Yasuda Method of fundamentally treating common cold
CN1457770A (en) * 2003-05-07 2003-11-26 苏晓林 Anti-virus arosol inhalation medicine liquid
CN1565475A (en) * 2003-04-25 2005-01-19 翁定高 Pertinent cure, immunity and prevention for atypical pneumonia, all kinds of virus infection of respiratory tract

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005802A1 (en) * 2000-07-17 2002-01-24 Saburo Yasuda Method of fundamentally treating common cold
CN1565475A (en) * 2003-04-25 2005-01-19 翁定高 Pertinent cure, immunity and prevention for atypical pneumonia, all kinds of virus infection of respiratory tract
CN1457770A (en) * 2003-05-07 2003-11-26 苏晓林 Anti-virus arosol inhalation medicine liquid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
龚亚红等: "围术期新型冠状病毒肺炎患者感染防控相关建议解读", 《临床麻醉学杂志》 *

Similar Documents

Publication Publication Date Title
TW201313265A (en) Inhalation systems, breathing apparatuses, and methods
CN106730188A (en) A kind of Respiratory Medicine is atomized chemical spraying device
CN204543165U (en) A kind of oxygen atomization administering medical liquids device
CN104208778B (en) Nebulization drug delivery system for respiratory circuit
CN108014099B (en) A kind of sucking tobramycin solution and preparation method thereof
CN206081256U (en) A multi -functional grafting device for trachea cannula
CN113041776A (en) Anesthesia department is with anesthesia waste gas pump drainage device
CN111419906A (en) Medicament for treating neocoronary pneumonia
CN103462942A (en) Suction-type ambroxol hydrochloride solution
CN201939830U (en) Oxygenating atomization inhalator
CN109432556A (en) A kind of intelligence pediatric drugs object atomizer and its application method
CN203342150U (en) Infant aerosol inhalation device
CN205268545U (en) Traditional chinese medicine fumigation inhaler
CN206120790U (en) Multi -purpose anesthesia machine, breathing machine return circuit sterilizing machine
CN204106767U (en) For the atomized medicine introducing system of breathing circuit
CN204521853U (en) A kind of autogenous cutting formula nebulizer
CN111265794A (en) Atomized traditional Chinese medicine gas dust filtration virus isolation inactivation respirator
CN207341993U (en) A kind of breathing catheter and moisture breathing medical device
CN201862088U (en) Medical sterilizing atomizer
CN207640760U (en) Gas compression formula children's nebulizer
CN202387070U (en) Sucking type oxygen atomizer of infant
CN213312616U (en) Lung rehabilitation treatment device
CN217886706U (en) Integrated form mesh screen atomizer
CN209137639U (en) Atomizer auxiliary storage mist device
CN219517474U (en) Oxygen inhalation heating and humidifying device for tracheotomy patient

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination